Zobrazeno 1 - 10
of 465
pro vyhledávání: '"Hiroki, Nishikawa"'
Autor:
Akira Imoto, Yuki Nagata, Yoshinori Shinohara, Hirota Miyazaki, Masanobu Fukumoto, Hidehiro Kitae, Masateru Asada, Masashi Noda, Kaoru Okada, Akira Asai, Kazuhide Higuchi, Hiroki Nishikawa
Publikováno v:
Case Reports in Gastroenterology, Vol 18, Iss 1, Pp 431-438 (2024)
Introduction: Fishbone (FB) ingestion is a rare cause of gastrointestinal perforation. Herein, we report a case of FB-induced colonic perforation, in which the presence of a penile colonic carcinoma may have contributed to the development of the perf
Externí odkaz:
https://doaj.org/article/df7f6f1e86ad467ab29508e1f282f55d
Autor:
Dai Okemoto, Toshifumi Yamaguchi, Mariko Yamaguchi, Toru Kadono, Hiroki Yukami, Elham Fakhrejahani, Hiroki Nishikawa
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1001-1007 (2024)
Introduction: In recent years, trastuzumab and pertuzumab have been used in treatment protocols for patients with HER2-positive colorectal cancer. Although severe thrombocytopenia is an uncommon side effect of anti-HER2 antibody therapy, we present t
Externí odkaz:
https://doaj.org/article/1642784669d742c396cf1d2633a51794
Autor:
Yuki Hirata, Yoshiki Tanaka, Haruka Yokota, Hiroshi Ohno, Koji Nishida, Hikaru Shimizu, Noboru Mizuta, Kei Nakazawa, Ryoji Koshiba, Kazuki Kakimoto, Takako Miyazaki, Shiro Nakamura, Hiroki Nishikawa
Publikováno v:
Gut Pathogens, Vol 16, Iss 1, Pp 1-5 (2024)
Abstract Background Immune checkpoint inhibitors (ICIs) are crucial in cancer treatment; however, they carry the risk of immune-related adverse events (irAEs), such as enteritis. Case presentation: This study investigated the role of the gut microbio
Externí odkaz:
https://doaj.org/article/2133d2f175724209a0931aea4e11aea9
Autor:
Shun Sasaki, Kazuhiro Ota, Makoto Sanomura, Yosuke Mori, Hironori Tanaka, Akitoshi Hakoda, Noriaki Sugawara, Taro Iwatsubo, Yuki Hirata, Kazuki Kakimoto, Hideaki Morita, Wataru Nagamatsu, Masaaki Hoshiga, Toshihisa Takeuchi, Kazuhide Higuchi, Hiroki Nishikawa
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Although proton pump inhibitors (PPIs) or potassium-competitive acid blocker (PCAB) are useful in peptic ulcer prevention, their efficacy in preventing other gastrointestinal bleeding remains unclear. This study aimed to identify
Externí odkaz:
https://doaj.org/article/f50ca14043de4b42b8c4ab13b9f5972a
Autor:
Takeshi Ogura, Saori Ueno, Akitoshi Hakoda, Atsushi Okuda, Nobu Nishioka, Jun Sakamoto, Masahiro Yamamura, Nobuhiro Hattori, Kimi Bessho, Hiroki Nishikawa, Rie Kanaoka, Youhei Kurose
Publikováno v:
Endoscopy International Open, Vol 12, Iss 08, Pp E955-E961 (2024)
Externí odkaz:
https://doaj.org/article/a0d61c38c61b436ca32313c069b93521
Autor:
Ausberto R. Velasquez Garcia, Linjun Yang, Hiroki Nishikawa, James S. Fitzsimmons, Adam J. Wentworth, Jonathan M. Morris, Michael J. Taunton, Shawn W. O'Driscoll
Publikováno v:
JSES International, Vol 8, Iss 6, Pp 1330- (2024)
Externí odkaz:
https://doaj.org/article/6bd85be1a4764182aadfc221f84c0e9c
Autor:
Noriaki Sugawara, Akitoshi Hakoda, Taro Iwatsubo, Shun Sasaki, Hironori Tanaka, Kazuhiro Ota, Hiroki Nishikawa
Publikováno v:
Endoscopy International Open, Vol 12, Iss 06, Pp E769-E771 (2024)
Externí odkaz:
https://doaj.org/article/889ec16922e64c5fb69fb494c1a5cfe7
Publikováno v:
IEEE Access, Vol 12, Pp 129753-129764 (2024)
Urine sediment analysis plays a vital role in the evaluation of kidney health. Traditional machine learning techniques approach the task of urine sediment particle detection as an image classification problem, wherein the particles are segmented base
Externí odkaz:
https://doaj.org/article/e9e840ee872e4758bce1ef3d6129fca4
Publikováno v:
IEEE Access, Vol 12, Pp 86906-86916 (2024)
This study develops a 3D sound localization platform specialized in evaluating the effect of synthetic reflected sounds. 3D sound localization is one of the promising technologies to realize a more realistic digital-twin world, and reflected sounds a
Externí odkaz:
https://doaj.org/article/96b09f221093400a9379579c4469136a
Autor:
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Keisuke Yokohama, Hiroki Nishikawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Atsushi Naganuma, Yutaka Yata, Hideko Ohama, Hidekatsu Kuroda, Kazunari Tanaka, Takaaki Tanaka, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, the Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 21680-21693 (2023)
Abstract Aim This retrospective study compared the impact of atezolizumab plus bevacizumab (Atez/Bev) and lenvatinib (LEN) on the liver function in patients with hepatocellular carcinoma. Methods We included 526 patients who received Atez/Bev and 731
Externí odkaz:
https://doaj.org/article/47d83858206f4fedb8133cae3683b6fd